You read this week’s publication New Cannabis Ventures Weekly Newsletter we publish from October 2015. We no longer send them. By mail as before but we post this and all newsletters On our website hereA number
Friends,
At the beginning of this year, Curaleaf lost the trial in the Michigan Federal Court and owes the plaintiff to Hello farms – $ 37.3 million.
Curaleaf revealed it in their quarterly performances last month.
The annual application of 2023 mentioned that the company has taken operations in Q3 and wanted to sell assets. The annual publication of 2024 revealed for sale of some assets, and the company was investigated by the state in 2020 and 2021 taxes, which began in 2024. It also started in 2024.
In March, the company appealed.
Here is the content table.
Hey, although it is unfortunate that cannabis is really federal illegal, can the industry use it as a reasoning that makes a sign. The contract between GR Midisary and Hello Farms required that GR VENING bought to go to Gauze from Hello Farms. GR Vending is grassy but the head of Khtrkh Was purchased in 2020A number of acquisition has been Declared in 2019 And the company expanded Michigan and several other states.
At the same time, when Curalef fights the plaintiff to make a decision, it does not pay 280 Tax. In August 2024, it is said that in its financial documents.
As of June 30, 2024, the company has adopted a new Federal and State Income Tax, claiming that the restrictions on Section 280 of the Internal Revenue Code (Section 280e) do not apply to the company’s cannabis. In addition, the company intends to amend the Federal and State Income Tax Income Tax Declarations for 2022 at the request of the company’s business.
The balance sheet has changed dramatically during the year, the last Q2 balance, which shows the income tax $ 6.26 million worth $ 6.2 million a year ago. It increased from 6/30/25 to $ 14.1 million, which is still low where they have changed. In June 2024, the uncertain tax position sharply expanded from $ 339.8 million to $ 79.1 million. It is now $ 476.9 million. In the first half of 2025, the company paid $ 20.9 million for taxes.
Disappointment is a big problem and losing in court causes a big problem. The lawsuit requires that the federal illegalism of cannabis does not mean that it is mandatory how to pay 280e taxes. If 280E taxation ends, the company may allow the decision to pay the verdict to the farm farms.
If 280E tax remains, Curalef must work with its terrible balance. At the end of Q2, it reported a total of $ 2.92 billion, which dropped by 1% from the end of the year. The total liabilities amounted to 1.98 billion dollars, and from the end of the year they rose by 1%. The total capital of $ 871.3 million, but this included in intangible $ 1.06 billion, and Gudvill – $ 636 million. Tangible equality – $ 824 million. The company’s debt amounted to 561 million dollars, the majority in 2026. About the call of the conference, General Director Boris Jordan suggested that the debt be refinanced until the end of the year.
Kiallen decreased by 22% to 22%, Jordan, Jordan and Executive Chairman and General Director since 2015. MSOS has made it the largest position, adding control of its shares more than 46%. The draft analysts of 2025 adjusted EBITDA by 2025, and a decline in 11% from 2024. The company has a worse balance, it feels that the adjusted EBITDA is reduced and I think is expensive.
The current assessment of the comparison of passioniffs is sufficient to remove investors from it, but another cannabis cannabis desire to make a decision to be illegal, alarming.
Frankly,
Alan
New hemp enterprises publish medicine articles, as well as exclusive news. Here is what we published this last week.
Exclusive
To get real-time updates follow Alan X.com:A number can also share and discover industry news along with sympathetic people, a large hemp group and entrepreneurship group ConnectionA number
Stay on top of some important communications of public companies by watching upcoming Cannabis Investor Calendar:A number
Based on the Houston, Alan cries out his experience as the founder of the online community 420 InvestorThe first and still the biggest decent diligent platform focused on the shares sold in the cannabis industry. Alan continues to find new ways to connect industry and facilitate its sustainable growth in the Canepuni community. Approximately New hemp enterprisesHe is responsible for content development and strategic alliances. Until the early 2013 focuses on the cannabis industry, Alan, who began his career in Wall Street, worked as more than two decades of research and portfolio. Article 650 of the Article 650 published in 2007 Looking for alphaWhere he has 70,000 followers, Alan is a frequent speaker for industry conferences and a Frequent source The media, including NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Ration | Facebook | Connection | Email
Michigan Hemp sale for August Falled a year ago, because they were 3.2% rose successively, which was the same during the day. For $ 283.3 million, sales decreased by 4.1% compared to the previous year.
The Michigan Kingdom Regulatory Agency is divided by the use of medical and adults by 61.0% a year earlier, reaching $ 1.5 million, increasing by 3.2% by 3.2%.
The state violates the sale by category and provides pricing details by category, both medical and adult use.
Adult usage
Medical
As the supply continues to expand, the pricing of flowers has fallen sharply to adults. In August, the average price of $ 989 for each pound, a new record, fell by 0.8% and decreased by 22.9% a year ago.
Michigan’s hemp sale from 2021 reaches 1.79 billion, from 2022 to $ 2.29 billion and 33.3% to $ 3.06 billion.
Based on the Houston, Alan cries out his experience as the founder of the online community 420 InvestorThe first and still the biggest decent diligent platform focused on the shares sold in the cannabis industry. Alan continues to find new ways to connect industry and facilitate its sustainable growth in the Canepuni community. Approximately New hemp enterprisesHe is responsible for content development and strategic alliances. Until the early 2013 focuses on the cannabis industry, Alan, who began his career in Wall Street, worked as more than two decades of research and portfolio. Article 650 of the Article 650 published in 2007 Looking for alphaWhere he has 70,000 followers, Alan is a frequent speaker for industry conferences and a Frequent source The media, including NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Ration | Facebook | Connection | Email
You read this week’s publication New Cannabis Ventures Weekly Newsletter we publish from October 2015. We no longer send them. By mail as before but we post this and all newsletters On our website hereA number
Friends,
On Friday, the S & P Dow Jones indicators announced that five shares will join the S & P / TSX composite index, including CURALAF. Since then, Curlf has earned 0.4%, rising a lot of Tuesday, but pulling yesterday. Not surprisingly, the company has a success in a press release on Monday morning, offering it to promote institutional property.
In late 2023, the Toronto Stock Exchange listed from the exchange of Canadian securities, where the market was originally entered. Terascend was the first to move to TSX, and the release moved to CAADA Conafe’s Curalaf transfer to TSX and which took place in 2023.
In two years or the way this MSOS has made their steps, no other MSOS followed. Considering that no other MSOS migrated to sleep from CSE because it did the same in the last 2023, probably doesn’t make it mean to do it. Of course, CSE has some challenges, but the bigger problem is that they are American companies. Where commercial problems are in the United States and not in Canada. Nothing against Canada but TSX list doesn’t actually change things. By the end of 2022 I called OTC as a Main potential catalystA number
In this newsletter of October 2023, I called it a waste of time To modernize TSX for American Cannabis. Looking at the price of prices, as this newsletter was published for the first degree and one of the second level, one of the nine MSOS gathered, and the rest decreased.
Readers should remember that the hemp section has decreased a lot in this moment, the NCV Global Cannabis stock index decreased by 16.6% to 6.90. The American Cannabis stock index decreased by 21.8%, and MSOS fell 34.0%. The average return of these 9 largest MSOS has even worse, but it greatly affects a murder, which has been suspended in Canada, but continues to trade on OTC.
Looking back, I would not conclude that trade exchange in Canada is generally important. One of the TSX listed shares did a little better than his peers, and one was bad. Much more than the Canadian listing drives drives the stock. I was shocked in June, when I was doing the quarterly redistribution of the Cannabis World Stock Index that the crankle was out due to insufficient trade. Only 3 MSOS qualified, resourceful and GTI and also glass home brands that trade in Canada (72.7% are increased from 10/30). In the past month, the volume of Curaleaf trade in Canada was 1,14 million shares, which is less than it trades on OTC. Perascend is 463k shares per year in the previous month, which is much less than an OTC average in one day 1 million shares. Looking at the other MSOS that trades on various exchanges in Canada, they have been a higher trade volume in OTC.
Kuralef and the tribe were so proud to discharge TSX in Canada two years ago, but it doesn’t really matter. How I used to say for several years now, what is 280e floor and OTC? I hope that 280 ends soon, but even if the hemp has resumed, there is no need to change the NASDAQ or NYSE about American hemp companies. I hope to change too.
Frankly,
Alan
New hemp enterprises publish medicine articles, as well as exclusive news. Here is what we published this last week.
To get real-time updates follow Alan X.com:Sharing a number and discover industry news along with supporters, the largest hemp group and entrepreneurs group ConnectionA number
Stay on top of some important communications of public companies by watching upcoming Cannabis Investor Calendar:A number
Based on the Houston, Alan cries out his experience as the founder of the online community 420 InvestorThe first and still the biggest decent diligent platform focused on the shares sold in the cannabis industry. Alan continues to find new ways to connect industry and facilitate its sustainable growth in the Canepuni community. Approximately New hemp enterprisesHe is responsible for content development and strategic alliances. Until the early 2013 focuses on the cannabis industry, Alan, who began his career in Wall Street, worked as more than two decades of research and portfolio. Article 650 of the Article 650 published in 2007 Looking for alphaWhere he has 70,000 followers, Alan is a frequent speaker for industry conferences and a Frequent source The media, including NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Ration | Facebook | Connection | Email
You read this week’s publication New Cannabis Ventures Weekly Newsletter we publish from October 2015. We no longer send them. By mail as before but we post this and all newsletters On our website hereA number
Friends,
The Cannabis Global stock index had a rough beginning until September. After 45.5% growth in August and increased by 54.2% after the end of the month, the figure decreased from 7.74 to 6.99 in just two days. The result is now only 1.6% per annum. The Great Cannabis Etf MSOS, which is 21.0%, decreased by 17.2% in late August.
Currently there are 23 shares in the Global Cannabis stock index, and they are now 39.2% now. The return frame is from -19.6% to + 186.0%.
There are more than doubled three shares in late June and 13 are two-digit winners. In the last 2nds of June, two shares that have been added to the index are double digit dismantling.
Leading three shares are Canadian LPs, and this newsletter has called the best two coats this year this year. Of course, I alerted here TILRAY is a dangerous stock On August 20, and while he fell a lot from his last peak, it is still higher than at that time (and it is dangerous to stay.)
Today I want to give some caution on some of these names and explain why I’m worried. I have written articles about some, looking for alpha, which are carbon (Tilre and farms), and I continue to be very negative on MSOS ETF (bad diversification). I will celebrate the shares that are in the Global Cannabis stock index, which depict me in alphabetical order.
Aurora Cannabis (ACB)I was closely following this one but it’s no longer on my focus list to 420 investors. The company exploded it in Canada’s adult market, but it has expanded internationally medical hemp. I don’t think the General Director has done a good job, and the shares that make up 15.4% a year as if they are not attractive.
Canopy growth (CGC): I’m closely following CGC and I have been very negative on it for a while. It has become exclusively cannabis, but it continues to harm its actions and fight with many debts. The share decreased by 49.1% to time, and I design it will post a new time low.
Glass Home Brands (Glasf)I don’t contain this one in my focus list, but I pay attention to it, because it is only three MSOS index. I like the CEO, but I think the stock is overestimated. Two investors have been supported who support the Fund very loudly. Glasf is 21.7% per annum.
Rhythm (force): This one, who was known as Agri, was difficult to start in September, but it is 23.0% per annum. I wrote about it before here and I’ve watched it even though it’s not in my focus list. I am interested, because the green thumb industry has such a large share. While I love the idea of haunting beverage-based drinks, the company has a lot of work to do to justify its mass assessment.
SNDL (SNDL): I don’t contain this one in my focus list, but I said to the CEO I like me. The company has what I consider bad MSOS, and it now trades on the value of a tangible book. It makes 40.5% a year.
TILRAY brands (TLRY): I started providing Tlry for a long time since I was not satisfied. I appreciate the better balance and likes what the company does with the drinks in the United States, but the fund, which now goes down by 10.9%, seems very expensive. Share-Count has exploded. One year from now on my target is essentially below if the shares trade and the company does not benefit from transformation.
Trulieve (TCNNF)To date, 44.7%, shares are cheaply designed with adjusted EBITDA. I think that the margins expected by analysts are too high, and I am very careful for Florida, where it is quite large. I also don’t like the balance sheet that has many tax liabilities. If 280E tax is clinging around, this one will fall sharply.
Village farms (VFF)Although it has fallen from the last peak, it still ends 234.6% a year. I think it’s a good company and looks like a transformation, but the fund looks ahead of her. The company could receive a medical cannabis license in Texas, but it may not be. I loved it under $ 1. While I don’t expect it to be a lot I think it could fall a lot.
I covered here just stocks that are in Cannabis Global Stock Index, although there are shares that are not in the indumin. I wrote about some of them while looking for Alpha and I recently parted the post in my blog some cannabis shares that refer to meA number
If I didn’t mention a share with me I don’t want readers to believe the name I like at the current price. My model portfolio has 19.3% cash in the 420 investors, which is about 20%, and positions in two Canadian LPS, two MSOS and three auxiliary names. I try to create a portfolio that has less flaws than Cannabis Global Stock Index.
Any trader or investor that counts 280e taxes can see this to happen. I don’t suppose that it will be, but luck for all those who bet it will be.
Frankly,
Alan
This week’s newsletter is sponsored by Paul. Sapperstein Co.
On September 16, community growth partners are auction in North Massachusetts, etc. All applications must be delivered online. Learn more About 219 points about the auction auction.
Interested parties can contact Michael Saperstein 617-227-6553 or email msaperstein@pesco.comA number
New hemp enterprises publish medicine articles, as well as exclusive news. Here is what we published this last week.
To get real-time updates as our Facebook page or follow Alan RationSharing a number and discover industry news along with supporters, the largest hemp group and entrepreneurs group ConnectionA number
Stay on top of some important communications of public companies by watching upcoming Cannabis Investor Calendar:A number
Based on the Houston, Alan cries out his experience as the founder of the online community 420 InvestorThe first and still the biggest decent diligent platform focused on the shares sold in the cannabis industry. Alan continues to find new ways to connect industry and facilitate its sustainable growth in the Canepuni community. Approximately New hemp enterprisesHe is responsible for content development and strategic alliances. Until the early 2013 focuses on the cannabis industry, Alan, who began his career in Wall Street, worked as more than two decades of research and portfolio. Article 650 of the Article 650 published in 2007 Looking for alphaWhere he has 70,000 followers, Alan is a frequent speaker for industry conferences and a Frequent source The media, including NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Ration | Facebook | Connection | Email
